secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001104659-22-114435
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech closes $3.0M private placement priced at $1.125 per share
-----------------------------------------------------------------------

- Sold 2,691,337 common shares with warrants to purchase up to 1,345,665 shares each (12-month $1.00 and 3-year $1.50 exercise).
- Gross proceeds ~$3.0M; net proceeds for Phase 2b allergic contact dermatitis study, working capital and general corporate purposes.
- Officers and directors purchased $0.5 million of the securities in the offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000110465922114435/0001104659-22-114435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000110465922114435/tm2229551d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-114435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer